scorecardresearch
Add as a preferred source on Google
Wednesday, December 10, 2025
TopicUSFDA

Topic: USFDA

First at-home Covid test gets approval — what this means, its impact & if it’s good news

USFDA Tuesday issued an emergency use authorisation to Lucira Health Inc.’s rapid-result Covid test, the first that can be used at home. Here's all you'd like to know about it.

USFDA approves first at-home test kit for detecting Covid

While some Covid tests allow people to to mail in samples collected at home, this is the first that can be fully self-administered & provides results at home in 30 minutes or less.

Eli Lilly’s Covid antibody drug gets emergency-use clearance by USFDA

The clearance gives doctors an option for tackling the coronavirus in high-risk patients before they’re sick enough to require hospitalization.

‘Deep state’ FDA is taking a beating as review of Covid vaccine approaches

At a time when the FDA needs the public’s trust more than ever, the US agency has been dragged into the political fray in a series of compounding incidents.

FDA wasn’t wrong in allowing plasma therapy for Covid patients in US

FDA's decision set off a media firestorm, with politicians, public-health officials & medical professionals insisting that the Trump administration was playing politics with science.

US FDA rows back on plasma therapy, says it doesn’t give dramatic benefit to Covid patients

FDA Commissioner Stephen Hahn had said Sunday that blood plasma from Covid-19 survivors given to new patients could save huge numbers of lives.

US FDA expands use of plasma therapy to treat Covid patients

The move will make it easier to receive the treatment, which Trump has promoted even though studies to prove its benefits haven’t been completed.

Pakistan has 1 lakh cases post lockdown, Sweden’s failed pandemic model & other Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

US drug regulator approves use of diabetes drug, also sold in India, to prevent heart attack

The drug Farxiga is sold in India by UK-based pharma giant AstraZeneca under the brand name ‘Forxiga’ to treat type 2 diabetes.

US FDA says smokers could have higher risk of catching coronavirus

FDA had earlier said smokers may have worse outcomes from Covid-19, but hadn’t been explicit about whether that included chances of infection in the first place.

On Camera

How China reads US National Security Strategy—a return of America First in new language

Across the varied reading of the NSS in Chinese media, one thread recurs: The more Trump leans toward isolationism, the more volatile the global order is likely to become.

Niti Aayog CEO has a message for power stakeholders. Buckle up for surge to feed EVs, data centres

Clean energy is “no longer the sideshow, it is the show”, BVR Subrahmanyam told the Odisha summit, warning India to lead the global shift or risk others’ tech dominance.

Dubai Tejas crash revives focus on advanced, fully automated safety systems

Dubai airshow crash & pilot death have rekindled concerns over pilot safety, and need for smarter automated systems that can step in when G-forces, temporary loss of consciousness hit the pilot.

Asim Munir & Pakistan’s Failed Marshal Doctrine

None of Pakistan’s PMs has lasted 5 years. That the current PM has given Asim Munir 5 years shows that of all military dictatorships history has seen, Pakistan’s is most creative.